Publications by authors named "Payam Tabarsi"

194Publications

Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion.

Sci Rep 2021 Jan 12;11(1):660. Epub 2021 Jan 12.

Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF
January 2021

Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients.

Int Immunopharmacol 2020 Dec 26;92:107329. Epub 2020 Dec 26.

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

View Article and Find Full Text PDF
December 2020

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).

Pulmonology 2020 Dec 4. Epub 2020 Dec 4.

Cell and Molecular Biology Group, Airways Disease Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK; Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.

View Article and Find Full Text PDF
December 2020

A Novel Coronavirus Disease (COVID-19): a Review of Host Cell Signaling Pathways.

Tanaffos 2020 Nov;19(2):108-111

Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF
November 2020

Immunopathogenesis of Pneumonia in COVID-19.

Tanaffos 2020 Nov;19(2):79-82

Clinical Tuberculosis and Epidemiology Research Center, (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF
November 2020

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.

Int Immunopharmacol 2021 Jan 13;90:107205. Epub 2020 Nov 13.

Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

View Article and Find Full Text PDF
January 2021

Correction to: Silent hypoxia: higher NO in red blood cells of COVID-19 patients.

BMC Pulm Med 2020 Nov 10;20(1):294. Epub 2020 Nov 10.

Cell and Molecular Biology Group, Airways Disease Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.

View Article and Find Full Text PDF
November 2020

Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial.

Int Immunopharmacol 2020 Dec 13;89(Pt B):107102. Epub 2020 Oct 13.

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

View Article and Find Full Text PDF
December 2020

Silent hypoxia: higher NO in red blood cells of COVID-19 patients.

BMC Pulm Med 2020 Oct 16;20(1):269. Epub 2020 Oct 16.

Cell and Molecular Biology Group, Airways Disease Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.

View Article and Find Full Text PDF
October 2020

Iran's Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials.

Front Public Health 2020 4;8:551889. Epub 2020 Sep 4.

Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF
September 2020

The Immune Response and Immunopathology of COVID-19.

Front Immunol 2020 26;11:2037. Epub 2020 Aug 26.

Respiratory Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

View Article and Find Full Text PDF
October 2020

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol.

Iran J Pharm Res 2020 ;19(1):31-36

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF
January 2020

Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces.

Iran J Pharm Res 2020 ;19(1):1-2

Student Research Committee, Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF
January 2020

MiRNAs in tuberculosis: Their decisive role in the fate of TB.

Eur J Pharmacol 2020 Nov 10;886:173529. Epub 2020 Sep 10.

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

View Article and Find Full Text PDF
November 2020

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.

Int Immunopharmacol 2020 Nov 4;88:106869. Epub 2020 Aug 4.

Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

View Article and Find Full Text PDF
November 2020